nucleoside reverse transcriptase inhibitor

GPTKB entity

Statements (65)
Predicate Object
gptkbp:instance_of gptkb:immunotherapy
gptkbp:administered_by oral medication
gptkbp:available_on generic medication
gptkbp:can_be_combined_with integrase inhibitors
gptkbp:can_cause gptkb:lipodystrophy
lactic acidosis
gptkbp:developed_by gptkb:1980s
pharmaceutical companies
https://www.w3.org/2000/01/rdf-schema#label nucleoside reverse transcriptase inhibitor
gptkbp:includes gptkb:abacavir
gptkb:lamivudine
gptkb:tenofovir
gptkb:zidovudine
gptkbp:ingredients infectious disease specialists
gptkbp:interacts_with protease inhibitors
non-nucleoside reverse transcriptase inhibitors
gptkbp:is_associated_with improved quality of life
adverse drug reactions
reduced transmission risk
improved life expectancy
reduced morbidity
gptkbp:is_considered treatment guidelines
gptkbp:is_effective_against HIV latent reservoirs
gptkbp:is_evaluated_by cost-effectiveness
efficacy
long-term effects
drug resistance
safety profile
gptkbp:is_monitored_by viral load
CD4 count
gptkbp:is_part_of gptkb:immunotherapy
combination therapy
global health initiatives
treatment regimens
HIV care continuum
HIV treatment guidelines
HAART regimen
gptkbp:is_recommended_for high-risk populations
gptkbp:is_regulated_by gptkb:FDA
gptkb:EMA
gptkbp:is_studied_for gptkb:cancer_treatment
HCV treatment
co-infections
other viral infections
gptkbp:is_subject_to clinical trials
gptkbp:is_used_in clinical practice
HIV prevention strategies
post-exposure prophylaxis
treatment-naive patients
pre-exposure prophylaxis
pediatric HIV treatment
treatment-experienced patients
gptkbp:mechanism_of_action inhibits reverse transcriptase
gptkbp:requires adherence to therapy
gptkbp:side_effect gptkb:anemia
fatigue
headache
nausea
gptkbp:suitable_for pregnant women without monitoring
gptkbp:targets gptkb:HIV-1
gptkb:HIV-2
gptkbp:used_for treatment of HIV
gptkbp:bfsParent gptkb:azidothymidine_(AZT)
gptkb:Biktarvy
gptkbp:bfsLayer 5